Actavis, Inc. (NYSE:ACT) is a dynamic leader in the global pharmaceutical marketplace and the world’s third largest pharmaceutical generics company, focused on developing, manufacturing and distributing more than 750 generic, brand and biosimilar products in more than 60 countries.Actavis is a market leader in the United States, Canada, Western Europe, Central and Eastern Europe, Russia, Southeast Asia and Australia, with 18 global R&D centers and income of more than 8 billion USD in 2012.Being a long term strategic partner and fully understanding their business, BSH (Bulgarian Software House) - one of the leading Microsoft Certified Partners in Bulgaria, was chosen to develop and implement the new Actavis portal.New portal is huge but perfectly integrated and centralized.
The portal was localized for 48 countries in 26 languages, and has regional sites for each country, where the conglomerate had a production, product development facility or representative office.Having the right skills set and experience, BSH used the latest technologies and best practices to deliver on-time the Actavis portal.
In January 2013, Actavis launched a brand new corporate Web site as part of a multi-year rebranding campaign that will consolidate its commercial presence around the world.The new Web site offers detailed information about the company, its global business and its various social responsibility initiatives.The Products section contains a comprehensive database with information about all Actavis generic and brand pharmaceutical products. Users can search the database by Product Name, Product Category or Product Index and find up-to-date product information, product labeling data and drug prescription information. The Investors section features press releases, financial and stock information and shareholder services.
The Web site also includes a searchable Careers section with all current US job openings and other career opportunities outside of the US.